2022
DOI: 10.1371/journal.pone.0276868
|View full text |Cite
|
Sign up to set email alerts
|

The effects of a 5-year physical activity on prescription (PAP) intervention in patients with metabolic risk factors

Abstract: Background Increased physical activity (PA) has positive effects on health and longevity. In Swedish healthcare, the physical activity on prescription (PAP) method reportedly increases patients’ PA levels for up to 12 months, but long-term follow ups are lacking. As it remains difficult to maintain lifestyle changes, our aim was to evaluate adherence and clinical effects at a 5-year follow-up of PAP treatment in primary healthcare. Methods This longitudinal, prospective cohort study included 444 patients, (5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 62 publications
0
2
0
Order By: Relevance
“…The effect size of 2.7 is a weighted average of the expected effects in the three stages i.e., 0.20 × 1 ml/kg/min (Stage C) ( 20 , 21 ) +0.30 × 2.5 ml/kg/min (Stage B) +0.50 × 3.5 ml/kg/min (Stage A) ( 22 , 23 ). A common standard deviation of 5, a correlation between baseline and 12 months equal to 0.50 and a drop-out rate at 12 months as high as 40% were assumed ( 24 ). However, the sample size will be increased to 312 patients in total (156 per group) such that for two key secondary outcomes standardized effect sizes as small as 0.45 and 0.40 can be detected with more than 90% and 80% power, respectively (using a cLDA model assuming—as for the primary outcome—a baseline-year correlation of 0.50% and 40% dropout at 12 months).…”
Section: Methodsmentioning
confidence: 99%
“…The effect size of 2.7 is a weighted average of the expected effects in the three stages i.e., 0.20 × 1 ml/kg/min (Stage C) ( 20 , 21 ) +0.30 × 2.5 ml/kg/min (Stage B) +0.50 × 3.5 ml/kg/min (Stage A) ( 22 , 23 ). A common standard deviation of 5, a correlation between baseline and 12 months equal to 0.50 and a drop-out rate at 12 months as high as 40% were assumed ( 24 ). However, the sample size will be increased to 312 patients in total (156 per group) such that for two key secondary outcomes standardized effect sizes as small as 0.45 and 0.40 can be detected with more than 90% and 80% power, respectively (using a cLDA model assuming—as for the primary outcome—a baseline-year correlation of 0.50% and 40% dropout at 12 months).…”
Section: Methodsmentioning
confidence: 99%
“…Swedish PAP has been shown to increase PA levels and lead to positive health effects among physically inactive patients [ 14 , 20 , 21 ]. Sustained effects of PAP have been shown on PA level, metabolic health, and health-related quality of life five years after a PAP intervention in Swedish primary care [ 22 ]. Patients with metabolic risk factors have described increased motivation for PA and that they experienced many health benefits after having received a tailored prescription for PA [ 23 ].…”
Section: Introductionmentioning
confidence: 99%